Tag: Group Leaders
Search News
Science and art collide at this year’s Royal Academy’s Summer Exhibition
21st June 2022
An artwork by Professor Tyson V. Sharp from Barts Cancer Institute at Queen Mary University of London has been selected for display in Room VIII at the Royal Academy of Art’s prestigious Summer Exhibition.
Read more
Investigating new treatment targets for lymphoma, and beyond
5th May 2022
We spoke with Dr John Riches, Clinical Senior Lecturer in the Centre for Haemato-Oncology at Barts Cancer Institute, Queen Mary University of London, about his team’s recent publication, which describes a new potential treatment target for a subset of lymphomas.
Read more
Prof Manchanda receives prestigious recognition from India’s leading medical school
17th March 2022
Congratulations to Professor Ranjit Manchanda from the CRUK Barts Centre who has been awarded the Distinguished Infosys Chair in Oncology at the All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Read more
Tackling blood cancer with Blood Cancer UK
10th September 2021
This Blood Cancer Awareness Month, find out about the Blood Cancer UK-funded research projects currently underway at the Barts Cancer Institute, which span from looking at the specific genetic changes that drive blood cancer development, to identifying new treatment strategies to improve the outcomes for patients.
Read more
BCI researcher receives UKRI Future Leaders Fellowship Award
9th September 2021
Dr Benjamin Werner from Barts Cancer Institute, Queen Mary University of London, is one of the next generation of UK science leaders to receive funding through UK Research and Innovation’s (UKRI) Future Leaders Fellowships scheme. Dr Werner will receive an award of approximately £1.4 million, which will support a research project looking at the evolutionary dynamics of circular extra-chromosomal DNA (ecDNA) in human cancers.
Read more
Research explainer with Dr Gabriella Ficz
28th September 2020
We spoke with Dr Gabriela Ficz to find out about her recent publication in Nature Communications. The study set out to determine how embryonic stem cells can acquire features that are found in cancer cells.
Read more